Association of bleeding symptoms during influenza infection and administered drugs.

Author: KatoYoko, MiyazakiChiaki, OhkusaYasushi, OkabeNobuhiko, SugawaraTamie, TaniguchiKiyosu

Paper Details 
Original Abstract of the Article :
On March 1, 2019, the Ministry of Health, Labour and Welfare added bleeding symptoms to adverse reaction package inserts as a possible adverse event for a new anti-influenza drug, baloxavir marboxil, because 13 patients with bleeding symptoms were identified among influenza patients taking the drug....See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.5582/ddt.2021.01085

データ提供:米国国立医学図書館(NLM)

Bleeding Symptoms During Influenza Infection

This study investigates the association between bleeding symptoms and administered drugs during influenza infection. Researchers conducted a survey among physicians in Japan during the 2019-2020 influenza season, gathering information about bleeding symptoms in influenza patients, including the medications they received. The study found that bleeding symptoms were reported in a small number of influenza patients, with a higher prevalence among hospitalized patients. While the survey data suggests a possible association between bleeding symptoms and certain medications, further research is needed to establish a definitive link.

Investigating the Potential Link Between Medications and Bleeding Symptoms

This study provides valuable information regarding the potential association between bleeding symptoms and medications administered during influenza infection. While the study found a possible link, further research with larger sample sizes and more rigorous methodology is needed to confirm these findings and establish a definitive causal relationship.

Navigating the Desert of Influenza

Imagine a desert landscape where influenza viruses can spread rapidly, causing illness and potential complications. This study, like a careful desert explorer, seeks to understand the potential connection between medications and bleeding symptoms, helping to ensure the safety of patients during influenza season.

Dr. Camel's Conclusion

This study sheds light on the potential association between bleeding symptoms and medications administered during influenza infection. While the study found a possible link, further research with larger sample sizes and more rigorous methodology is needed to confirm these findings and establish a definitive causal relationship. It’s important to note that this research highlights the need for ongoing vigilance and thorough investigation to ensure the safety and effectiveness of medications during influenza season.
Date :
  1. Date Completed 2022-01-13
  2. Date Revised 2022-01-13
Further Info :

Pubmed ID

34719605

DOI: Digital Object Identifier

10.5582/ddt.2021.01085

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.